Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$0.5 - $0.73 $152,148 - $222,136
304,296 New
304,296 $162,000
Q2 2023

Jul 27, 2023

BUY
$0.55 - $0.89 $191,026 - $309,115
347,321 New
347,321 $265,000
Q4 2022

Feb 15, 2023

BUY
$0.96 - $1.34 $165,105 - $230,459
171,985 New
171,985 $177,000
Q2 2022

Aug 09, 2022

SELL
$0.94 - $1.94 $101,945 - $210,398
-108,453 Reduced 67.49%
52,233 $54,000
Q1 2022

May 17, 2022

BUY
$1.54 - $3.71 $247,456 - $596,145
160,686 New
160,686 $317,000
Q4 2021

Feb 17, 2022

SELL
$2.58 - $3.91 $219,354 - $332,432
-85,021 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$2.77 - $4.05 $174,019 - $254,433
-62,823 Reduced 42.49%
85,021 $288,000
Q2 2021

Sep 17, 2021

BUY
$1.71 - $4.14 $252,813 - $612,074
147,844 New
147,844 $568,000
Q1 2021

May 19, 2021

SELL
$0.85 - $5.27 $72,051 - $446,716
-84,766 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$0.36 - $0.95 $30,515 - $80,527
84,766 New
84,766 $74,000
Q3 2020

Dec 11, 2020

SELL
$0.36 - $0.53 $39,335 - $57,909
-109,264 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$0.39 - $0.69 $29,324 - $51,881
-75,190 Reduced 40.76%
109,264 $43,000
Q4 2019

Feb 04, 2020

BUY
$0.83 - $1.3 $153,096 - $239,790
184,454 New
184,454 $169,000
Q3 2019

Nov 20, 2019

SELL
$0.97 - $1.94 $51,401 - $102,802
-52,991 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$1.81 - $2.45 $95,913 - $129,827
52,991 New
52,991 $108,000
Q2 2018

Jul 30, 2018

SELL
$3.03 - $4.98 $99,171 - $162,995
-32,730 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$3.03 - $4.98 $99,171 - $162,995
32,730 New
32,730 $135,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $363M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.